Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Myelofibrosis

Clinical Trial at: Texas Oncology - Denton

INCB 39110-209, An Open-Label Phase 2 Study of Itacitinib (INCB039110) in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis

  • Details

ClinicalTrials.gov ID: NCT03144687
Diagnosis Type: NA
USOR Number: 17085

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Denton

TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency - CO-338-052

  • Details

ClinicalTrials.gov ID: NCT02952534
Diagnosis Type: NA
USOR Number: 16237

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Denton

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Denton

An Open-Label, Multicenter, Phase 1/2 Study of Tazemetostat (EZH2 Histone Methyl Transferase [HMT] Inhibitor) as a Single Agent in Subjects With Advanced Solid Tumors or With B Cell Lymphomas and Tazemetostat in Combination With Prednisolone in Subjects With Diffuse Large B Cell Lymphoma - E7438-G000-101

  • Details

ClinicalTrials.gov ID: NCT01897571
Diagnosis Type: Non-Hodgkins
USOR Number: 16248

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Denton

(I3Y-MC-JPCF) monarchE: A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer

  • Details

ClinicalTrials.gov ID: NCT03155997
Diagnosis Type: NA
USOR Number: 17082

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Denton

ONT-380-206 - Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma (HER2CLIMB) (ONT-380-206)

  • Details

ClinicalTrials.gov ID: NCT02614794
Diagnosis Type: NA
USOR Number: 16195

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Denton

A Phase 2, Open-label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Metastatic or Surgically Unresectable Urothelial Carcinoma Haboring FGF/FGFR Alterations

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Denton

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Denton

A Phase 2, Open-label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Metastatic or Surgically Unresectable Urothelial Carcinoma Haboring FGF/FGFR Alterations

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Colon Cancer

Clinical Trial at: Texas Oncology - Denton

CanStem303C: A Phase III Study of BBI-608 in combination with 5-Fluorouracil, Leucovorin, Irinotecan (FOLFIRI) in Adult Patients with Previously Treated Metastatic Colorectal Cancer (CRC)

  • Details

ClinicalTrials.gov ID: NCT02753127
Diagnosis Type: NA
USOR Number: 16130

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Denton

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Rectal Cancer

Clinical Trial at: Texas Oncology - Denton

CanStem303C: A Phase III Study of BBI-608 in combination with 5-Fluorouracil, Leucovorin, Irinotecan (FOLFIRI) in Adult Patients with Previously Treated Metastatic Colorectal Cancer (CRC)

  • Details

ClinicalTrials.gov ID: NCT02753127
Diagnosis Type: NA
USOR Number: 16130

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Melanoma

Clinical Trial at: Texas Oncology - Denton

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Denton

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer (NRG-BR003)

  • Details

ClinicalTrials.gov ID: NCT02488967
Diagnosis Type: NA
USOR Number: 15146

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Renal Cancer

Clinical Trial at: Texas Oncology - Denton

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Texas Oncology - Denton

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Denton

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Texas Oncology - Denton

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Plano

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

3705 West 15th Street
Plano, Texas 75075
287.21 mi. away
P: (972) 867-3577

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Plano

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)

  • Details

ClinicalTrials.gov ID: NCT03053193
Diagnosis Type: NA
USOR Number: 17079

  • Practice Details

3705 West 15th Street
Plano, Texas 75075
287.21 mi. away
P: (972) 867-3577

More Details View Practice Page

Pages